A detailed history of Caxton Corp transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Caxton Corp holds 18,403 shares of CNTX stock, worth $18,771. This represents 0.15% of its overall portfolio holdings.

Number of Shares
18,403
Previous 18,403 -0.0%
Holding current value
$18,771
Previous $36,000 -0.0%
% of portfolio
0.15%
Previous 0.19%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.24 - $2.19 $22,819 - $40,302
18,403 New
18,403 $36,000

Others Institutions Holding CNTX

About Context Therapeutics Inc.


  • Ticker CNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,966,100
  • Market Cap $16.3M
  • Description
  • Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...
More about CNTX
Track This Portfolio

Track Caxton Corp Portfolio

Follow Caxton Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Corp, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Corp with notifications on news.